新闻中心
NEWS
新闻中心

2021-004 Yan'an Pharmaceutical: Announcement on the proposed revision of the "Articles of Association"

classification： Notice

Time：2021-10-14 16:37

1. The revised content
According to the "Company Law", "Measures for the Supervision and Management of Non-listed Public Companies" and the "Articles of Association" and other relevant regulations, the company intends to amend some of the provisions of the "Articles of Association". The revisions are as follows:

Original regulations

After revision

Article 4 Company domicile: Room 502, Unit 2, Building 6, Yangpu Puruihaoyuan.

Article 4 Company domicile: Floor Floor, No. 6, High-end Tourism Consumer Goods Manufacturing Industrial Park, Bonded Port Zone, Xinying Bay District, Yangpu Economic Development Zone, Hainan Province.

Article 12 After being registered in accordance with the law, the company’s business scope includes: Chinese patent medicines, chemical raw materials and their preparations, antibiotic raw materials and their preparations, biochemical drugs, packaging materials, daily necessities, Wujinjiaodian, testing equipment , Cosmetics, chemical raw materials (except dangerous goods), pharmaceutical excipients sales, import and export business, the production and sales of medical devices Class I, II, III, e-commerce (no financial business), design, production, agency, Publish all kinds of advertisements, corporate management consulting (excluding financial investment, asset management), cultural and artistic exchange planning, marketing planning, e-commerce information consulting, technical consulting, technical services, technology development, and technology transfer in the field of medical science and technology. (General operating projects are operated independently, and permitted operating projects are operated with relevant licenses or approval documents) (Projects that are subject to approval in accordance with the law can only be operated after approval by relevant departments.)

Article 12 After being registered in accordance with the law, the company’s business scope includes: Chinese patent medicines, chemical raw materials and their preparations, antibiotic raw materials and their preparations, biochemical drugs, packaging materials, daily necessities, Wujinjiaodian, testing equipment , Cosmetics, chemical raw materials (except dangerous goods), Sales of pharmaceutical excipients, production of cosmetics, production and sales of food and health products, import and export business,Medical devices Class I, II, III Production, sales, e-commerce (not engaged in financial business), design, production, agency, and release of various advertisements, corporate management consulting (excluding financial investment, asset management), cultural and artistic exchange planning, marketing planning, e-commerce information Consulting, engaging in technical consulting, technical services, technology development, and technology transfer in the field of medical science and technology. (General operating projects are operated independently, and permitted operating projects are operated with relevant licenses or approval documents) (Projects that are subject to approval in accordance with the law can only be operated after approval by relevant departments.)

Except for the above-mentioned amendments, other provisions of the original "Articles of Association" remain unchanged, and the foregoing content still needs to be submitted to the company's general meeting of shareholders for deliberation, which is subject to registration by the administrative department for industry and commerce.
2. Reasons for revision
The company changes its registered address and increases part of its business scope due to business needs, which will not adversely affect the company's operations.

3. Documents for reference
Resolutions of the Twelfth Meeting of the Second Board of Directors of Shanghai Yan'an Pharmaceutical Yangpu Co., Ltd.

Shanghai Yan'an Pharmaceutical Yangpu Co., Ltd.
Board of Directors
March 18, 2021

Back list